Huntsworth Health’s ApotheCom Group and Continuum Clinical have joined forces to create a new real-world evidence (RWE) offering for pharmaceutical clients worldwide.
The medical communications agency and patient recruitment and research company will build upon their ongoing partnership to launch a series of new market access, medical affairs and health economics and outcomes research (HEOR) services next year.
Chief among these will be RWE strategy and communication, using Continumm’s expertise to create and ApotheCom’s to deliver evidence of clinical, economic and patient value that can enhance the market access dialogue.
Nathan White, executive vice president and global practice lead for access pathways and outcomes at ApotheCom, said: “The deep expertise in real world evidence development that Continuum brings to the workbench is a brilliant, natural fit for what we’re doing at ApotheCom.
“Our experience in the strategic planning and communication of compelling RWE that payers and health technology assessment desperately need in order to make informed decisions, combined with Continuum’s experience in creating RWE, will be a significant value addition to our existing client base.”
With a combined total of over 280 employees specialising in clinical, scientific, health outcomes, market access, observational research and marketing spread across North America, Europe and Asia, the partners hope to create a single, integrated, cost-saving business structure for the life science industry.
Les Noe, executive vice president, health economics and outcomes research at Continuum Clinical, said: “We’re delighted to expand on our business relationship with ApotheCom.
“Working together we can truly strive to impact and improve on outcomes for our clients and their stakeholders.”